ICON Public Limited Company
NASDAQ:ICLRMedical - Diagnostics & Research
-$0.27 today
- Market cap
- $14.62B
- Beta
- 1.27
- P/E (TTM)
- 23.0
- EPS (TTM)
- $6.23
Volume 0.55M
Average 1.15M
ICLR Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
ICON Public Limited CompanyNASDAQ: ICLR
Gross Margin · Q2 FY2026 · quarter ended Jun 2026
Gross margin narrows to 18.8%
Gross margin was 18.8% in Q2 FY2026, down 9.0 pp from a year earlier. On a trailing-twelve-month basis it was 21.8%, down 6.7 pp year over year. Over 3 fiscal years it narrowed by 2.2 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 26.4%
- Year-over-year change
- -3.1pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.4% | -3.1pp |
| FY2024 | 2024-12-31 | 29.4% | -0.1pp |
| FY2023 | 2023-12-31 | 29.6% | +1.0pp |
| FY2022 | 2022-12-31 | 28.6% | +1.1pp |
| FY2021 | 2021-12-31 | 27.5% | — |
Gross Margin vs competitors
How ICLR compares with its peers on the latest reported figures
- ICLR's LTM Jun 2026 gross margin of 21.8% is the 5th highest of the 6 companies compared; the peer median is 27.8%.
- Its year-over-year change of -6.7 pp is the 5th highest of 6, against a peer median of -1.9 pp.
- Over three fiscal years its change of -2.2 pp compares with a peer median of -4.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 32.2% | -0.2 pp | -6.3 pp | |
| LTM Sep 2026 | 29.1% | -2.0 pp | +0.4 pp | |
| LTM Jun 2026 | 27.8% | -0.3 pp | -4.5 pp | |
| LTM Jun 2026 | 26.2% | -8.0 pp | -1.6 pp | |
| LTM Jun 2026 | 21.8% | -6.7 pp | -2.2 pp | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | 17.1% | -1.9 pp | -9.9 pp |
| Peer median (excluding ICLR) | 27.8% | -1.9 pp | -4.5 pp | |
Competitors are the stored peer set for ICLR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.48B | 7.74B | 8.12B | 8.28B | 8.25B |
| Cost of Revenue | 3.97B | 5.53B | 5.72B | 5.85B | 6.08B |
| Gross Profit | 1.51B | 2.21B | 2.4B | 2.44B | 2.18B |
| Gross Margin | 27.5% | 28.6% | 29.6% | 29.4% | 26.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 585.33M | 778.75M | 776.36M | 728.35M | 780.14M |
| Operating Expenses | 1.13B | 1.42B | 1.44B | 1.34B | 1.16B |
| Depreciation & Amortization | 314.99M | 569.51M | 585.95M | 488.5M | 383M |
| EBITDA | 694.09M | 1.37B | 1.52B | 1.56B | 823.57M |
| EBITDA Margin | 12.7% | 17.7% | 18.7% | 18.9% | 10.0% |
| Operating Income | 378.53M | 795.24M | 956.15M | 1.1B | 1.01B |
| Operating Margin | 6.9% | 10.3% | 11.8% | 13.3% | 12.3% |
| Interest Income | 574K | 2.35M | 5.01M | 8.61M | 7.11M |
| Interest Expense | 182.42M | 229.73M | 336.7M | 237.24M | 188.11M |
| Other Income / Expenses | (184.01M) | (230.52M) | (331.69M) | (228.63M) | (759.99M) |
| Income Before Tax | 194.52M | 564.72M | 624.08M | 869.18M | 252.47M |
| Pre-Tax Margin | 3.5% | 7.3% | 7.7% | 10.5% | 3.1% |
| Income Tax Expense | 41.33M | 59.41M | 11.75M | 77.71M | 23.13M |
| Net Income | 153.19M | 505.3M | 612.34M | 791.47M | 229.34M |
| Net Margin | 2.8% | 6.5% | 7.5% | 9.6% | 2.8% |
| EPS (Basic) | 2.28 | 6.20 | 7.46 | 9.60 | 2.92 |
| EPS (Diluted) | 2.25 | 6.13 | 7.40 | 9.53 | 2.90 |
| Weighted Avg Shares | 67.11M | 81.53M | 82.1M | 82.48M | 78.42M |
| Weighted Avg Shares (Diluted) | 68.07M | 82.47M | 82.72M | 83.03M | 78.97M |
ICON Public Limited Company
NASDAQ:ICLR
Intrinsic Alpha fair value
Locked
Current Price
$195.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.